132 related articles for article (PubMed ID: 37401353)
1. The impact of anticipatory care on the therapeutic effectiveness and quality of life of lymphoma patients undergoing autologous hematopoietic stem cell transplantation.
Ma Y; Wei F; Wang A
Minerva Pediatr (Torino); 2024 Feb; 76(1):135-138. PubMed ID: 37401353
[No Abstract] [Full Text] [Related]
2. Combined use of multiday palonosetron with aprepitant and low-dose dexamethasone in prevention of nausea and emesis among patients with multiple myeloma and lymphoma undergoing autologous hematopoietic stem cell transplant: A pilot study.
Deauna-Limayo D; Aljitawi OS; Ganguly S; Abhyankar S; Wick JA; McGuirk JP
J Oncol Pharm Pract; 2014 Aug; 20(4):263-9. PubMed ID: 24005093
[TBL] [Abstract][Full Text] [Related]
3. Autologous peripheral blood stem cell transplantation in patients with relapsed lymphoma results in accelerated haematopoietic reconstitution, improved quality of life and cost reduction compared with bone marrow transplantation: the Hovon 22 study.
Vellenga E; van Agthoven M; Croockewit AJ; Verdonck LF; Wijermans PJ; van Oers MH; Volkers CP; van Imhoff GW; Kingma T; Uyl-de Groot CA; Fibbe WE
Br J Haematol; 2001 Aug; 114(2):319-26. PubMed ID: 11529850
[TBL] [Abstract][Full Text] [Related]
4. Cost analysis and quality of life assessment comparing patients undergoing autologous peripheral blood stem cell transplantation or autologous bone marrow transplantation for refractory or relapsed non-Hodgkin's lymphoma or Hodgkin's disease. a prospective randomised trial.
van Agthoven M; Vellenga E; Fibbe WE; Kingma T; Uyl-de Groot CA
Eur J Cancer; 2001 Sep; 37(14):1781-9. PubMed ID: 11549432
[TBL] [Abstract][Full Text] [Related]
5. Autologous hematopoietic stem cell transplantation with inadequate stem cell dose in patients with non-Hodgkin lymphoma.
Liu W; Wu M; Xie Y; Zhang C; Ping L; Feng F; Leng X; Mi L; Wang X; Zhu J; Song Y
Leuk Lymphoma; 2021 Feb; 62(2):323-329. PubMed ID: 33054458
[TBL] [Abstract][Full Text] [Related]
6. [Efficiency and safety analysis of Plerixafor combined with granulocyte colony-stimulating factor on autologous hematopoietic stem cell mobilization in lymphoma].
Ji MM; Shen YG; Gong JC; Tang W; Xu XQ; Zheng Z; Chen SY; He Y; Zheng X; Zhao LD; Zhao WL; Wu W
Zhonghua Xue Ye Xue Za Zhi; 2023 Feb; 44(2):112-117. PubMed ID: 36948864
[No Abstract] [Full Text] [Related]
7. Daily Weight-Based Busulfan with Cyclophosphamide and Etoposide Produces Comparable Outcomes to Four-Times-Daily Busulfan Dosing for Lymphoma Patients Undergoing Autologous Stem Cell Transplantation.
Hill BT; Rybicki L; Carlstrom KD; Jagadeesh D; Gerds A; Hamilton B; Liu H; Dean R; Sobecks R; Pohlman B; Andresen S; Kalaycio M; Bolwell BJ; Majhail NS
Biol Blood Marrow Transplant; 2016 Sep; 22(9):1588-1595. PubMed ID: 27343718
[TBL] [Abstract][Full Text] [Related]
8. [Combined high dose chemotherapy with autologous stem cell transplantation and total body radiotherapy for 32 malignant lymphoma patients].
Wang H; Cui X; Shao Y
Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):436-8. PubMed ID: 11810783
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the Impact of Autologous Hematopoietic Stem Cell Transplantation on the Quality of Life of Older Patients with Lymphoma.
Lemieux C; Ahmad I; Bambace NM; Bernard L; Cohen S; Delisle JS; Fleury I; Kiss T; Mollica L; Roy DC; Sauvageau G; Roy J; Lachance S
Biol Blood Marrow Transplant; 2020 Jan; 26(1):157-161. PubMed ID: 31521818
[TBL] [Abstract][Full Text] [Related]
10. Randomized comparison of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin chemotherapy before autologous stem-cell transplantation for relapsed and refractory aggressive lymphomas: NCIC-CTG LY.12.
Crump M; Kuruvilla J; Couban S; MacDonald DA; Kukreti V; Kouroukis CT; Rubinger M; Buckstein R; Imrie KR; Federico M; Di Renzo N; Howson-Jan K; Baetz T; Kaizer L; Voralia M; Olney HJ; Turner AR; Sussman J; Hay AE; Djurfeldt MS; Meyer RM; Chen BE; Shepherd LE
J Clin Oncol; 2014 Nov; 32(31):3490-6. PubMed ID: 25267740
[TBL] [Abstract][Full Text] [Related]
11. Sarcopenia Predicts Inferior Progression-Free Survival in Lymphoma Patients Treated with Autologous Hematopoietic Stem Cell Transplantation.
Sumransub N; Cao Q; Juckett M; Betts B; Holtan S; Jurdi NE; Hu M; Allred J; Assi R; Maakaron JE
Transplant Cell Ther; 2023 Apr; 29(4):263.e1-263.e7. PubMed ID: 36682471
[TBL] [Abstract][Full Text] [Related]
12. Dendritic cells in autologous hematopoietic stem cell transplantation for diffuse large B-cell lymphoma: graft content and post transplant recovery predict survival.
Dean R; Masci P; Pohlman B; Andresen S; Serafino S; Sobecks R; Kuczkowski E; Curtis J; Maciejewski J; Rybicki L; Kalaycio M; Hsi E; Theil K; Bolwell BJ
Bone Marrow Transplant; 2005 Dec; 36(12):1049-52. PubMed ID: 16247431
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the risk factors associated with high-dose chemotherapy-induced dysgeusia in patients undergoing autologous hematopoietic stem cell transplantation: possible usefulness of cryotherapy in dysgeusia prevention.
Okada N; Hanafusa T; Abe S; Sato C; Nakamura T; Teraoka K; Abe M; Kawazoe K; Ishizawa K
Support Care Cancer; 2016 Sep; 24(9):3979-85. PubMed ID: 27129837
[TBL] [Abstract][Full Text] [Related]
14. [IEAC versus CEAC high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation for lymphoma: analysis of efficacy and safety in 106 cases].
Xiong Y; Chen J; Liu L; Luo X; Tang X; Wang X; Xiao Q; Zhang H; Wang L
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Dec; 40(12):1760-1767. PubMed ID: 33380399
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy and Safety of Plerixafor Combined with G-CSF for Autologous Peripheral Blood Hematopoietic Stem Cell Mobilization in Lymphoma Patients].
Guan FS; He DH; Li Y; Zhang Y; Zheng GF; Zhu YY; He JS; Zhang EF; Cai Z; Zhao Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Aug; 31(4):1056-1060. PubMed ID: 37551477
[TBL] [Abstract][Full Text] [Related]
16. [Clinical Analysis of Autologous Peripheral Blood Hematopoietic Stem Cells Mobilization and Collection in Lymphoma Patients].
Liu H; Xi R; Bai H; Wu T
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1845-1851. PubMed ID: 38071071
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety of Synbiotics in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation: A Randomized, Double-blinded, Placebo-controlled Pilot Study.
Mizutani Y; Kawamoto S; Takahashi M; Doi H; Wakida K; Tabuchi S; Tanda M; Soga A; Chijiki R; Takakura H; Kawaguchi K; Higashime A; Watanabe M; Ichikawa H; Matsumoto S; Sakai R; Goto H; Kurata K; Kakiuchi S; Miyata Y; Uryu K; Inui Y; Kitao A; Yakushijin K; Matsuoka H; Minami H
Intern Med; 2023 Oct; 62(20):2949-2958. PubMed ID: 36792187
[TBL] [Abstract][Full Text] [Related]
18. Hematopoietic stem cell transplantation in the treatment of lymphoma.
Bregni M; Siena S
Curr Opin Oncol; 1991 Oct; 3(5):838-42. PubMed ID: 1684293
[TBL] [Abstract][Full Text] [Related]
19. [Effects of Hepatovirus B Infection on the Hematopoietic Stem Cell Collection and Implantment in Lymphoma Patients Received Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation].
Wang XN; He PC; Guo CL; Sun CH; Zhang M; Liu HS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1397-1403. PubMed ID: 27784364
[TBL] [Abstract][Full Text] [Related]
20. A gemcitabine-based regimen followed by autologous stem cell transplantation show high efficacy and well tolerance in malignant lymphoma.
Liu H; Liu W; Li R; Jiao Y; Huang W; Yi S; Lv R; Deng S; An G; Wang T; Sui W; Fu M; Zhao Y; Qiu L; Zou D
Bone Marrow Transplant; 2022 Jun; 57(6):1017-1020. PubMed ID: 35393527
[No Abstract] [Full Text] [Related]
[Next] [New Search]
